Terug
Dagbereik
€ 19,91
€ 21,17
52-Weeksbereik
€ 5,15
€ 27,65
Volume
1.181.672
50D / 200D Gem.
€ 22,70
/
€ 15,69
Vorige Slotkoers
€ 20,75
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -8,4 | 0,3 |
| P/B | 2,8 | 2,9 |
| ROE % | -52,1 | 3,7 |
| Net Margin % | -3060,0 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 36,83
+82.2%
Low: € 32,00
High: € 40,00
Forward WPA
-€ 2,41
Omzet Sch.
4,4 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,36
-€ 0,14 – € 3,69
|
620 M | 6 |
| FY2029 |
-€ 0,06
-€ 0,16 – € 0,01
|
400 M | 6 |
| FY2028 |
-€ 1,18
-€ 2,86 – -€ 0,48
|
240 M | 8 |
Belangrijkste Punten
Debt/Equity of 0,01 — conservative balance sheet
Negative free cash flow of -200,60M
PEG of 0,17 suggests growth is underpriced
Capital intensive — 139,53% of revenue goes to capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)-23,23%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-52,09%
ROIC-25,16%
Net Margin-3059,99%
Op. Margin-3084,76%
Veiligheid
Debt / Equity
0,01
Current Ratio14,69
Interest Coverage0,00
Waardering
P/E Ratio
-8,36
P/B Ratio2,80
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -23,23% | Revenue Growth (3Y) | -29,63% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 6,94M | Net Income (TTM) | -212,39M |
| ROE | -52,09% | ROA | -31,09% |
| Gross Margin | 57,43% | Operating Margin | -3084,76% |
| Net Margin | -3059,99% | Free Cash Flow (TTM) | -200,60M |
| ROIC | -25,16% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 14,69 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -8,36 | P/B Ratio | 2,80 |
| P/S Ratio | 255,82 | PEG Ratio | 0,17 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,78B | Enterprise Value | 1,13B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6,94M | 9,04M | 14,02M | 0,0 | 0,0 |
| Net Income | -212,39M | -292,96M | -106,81M | -36,90M | -24,71M |
| EPS (Diluted) | -2,43 | -5,00 | -5,38 | -3,09 | -2,14 |
| Gross Profit | 3,99M | 9,04M | 14,02M | 0,0 | 0,0 |
| Operating Income | -214,11M | -305,80M | -109,53M | -36,90M | -25,20M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 683,19M | 240,24M | 148,54M | 24,05M | 57,93M |
| Total Liabilities | 48,85M | 59,08M | 28,66M | 7,39M | 9,74M |
| Shareholders' Equity | 634,34M | 181,17M | 119,88M | 16,65M | 48,19M |
| Total Debt | 3,86M | 4,83M | 1,65M | 291.000,0 | 317.000,0 |
| Cash & Equivalents | 653,48M | 143,35M | 98,68M | 20,32M | 49,23M |
| Current Assets | 660,78M | 221,34M | 144,70M | 22,65M | 56,64M |
| Current Liabilities | 44,99M | 54,31M | 21,83M | 7,33M | 9,73M |